Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2361 - 2368 of 12085 results
Energy & Sustainability M&A Activity — July 2022
July 18, 2022| Article| Viewpoint
Energy & Sustainability Event Highlights — July 2022
July 18, 2022| Article| Viewpoint
Charting New (and Familiar) Territory: The Voyager Crypto Bankruptcy
July 18, 2022| Blog| Viewpoint
Health Law Diagnosed – Medical-Legal Partnerships: Leveraging a Cross-Disciplinary Approach to Improve Health Outcomes
July 18, 2022| Podcast| Viewpoint
Private equity deals slow in Canada, signalling risks ahead
July 18, 2022| News
How USPTO Pharma Reform Could Lower Counsel Spend
July 15, 2022| News
Rule 11 Sanctions Appropriate for Frivolous Inventorship Pleading
July 13, 2022| Blog| Viewpoint
SCOTUS Declines to Answer Calls for Clarification in American Axle v. Neapco
July 13, 2022| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|